Bloomberg News

Roche May Abandon its Bid for Illumina, SonntagsZeitung Reports

April 01, 2012

Roche Holding AG (ROG), a Basel, Switzerland-based drugmaker, may drop its $6.6 billion bid for Illumina Inc. (ILMN:US), SonntagsZeitung reported, citing an unidentified person close to Roche’s board.

San Diego, California-based Illumina, a diagnostics company, can’t rely on Roche’s continuing participation in negotiations, the person said, adding that for Roche, Illumina is a “nice-to-have,” not a “must-have,” the Swiss newspaper reported.

To contact the reporter on this story: Leigh Baldwin in Zurich at

To contact the editor responsible for this story: Mariajose Vera at

Race, Class, and the Future of Ferguson

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Companies Mentioned

  • ILMN
    (Illumina Inc)
    • $172.0 USD
    • -0.09
    • -0.05%
Market data is delayed at least 15 minutes.
blog comments powered by Disqus